Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$2.23 -0.03 (-1.11%)
As of: Sep 4, 2026 · 3:17 PM EDT

Lexicon Pharmaceuticals (LXRX) Non-cash Items (2025)

Analysis

Lexicon Pharmaceuticals (LXRX) Non-cash Items (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Lexicon Pharmaceuticals 978.15 Mn 787.54 Mn 653,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.50 Mn